**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide/tirzepatide for weight loss and related outcomes within the WW Clinic Program who increased their Healthy Eating Index score from 55.0 to 65.1
doi:10.1016/j.clbc.2017.11.006 Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML
We believe in compassionate care that respects every individuals unique journey, combining advanced medical science with modern technology
Losing weight can disrupt hunger hormones like ghrelin and leptin, which can lead to more cravings and poor sleep
The logic is that GH-axis compounds are not dose-linear in a helpful way past a point: once the pulse is being driven hard, adding drug mostly buys more IGF-1 exposure, more fluid retention and more glucose disturbance rather than proportionally more benefit